Los Angeles Capital Management LLC Sells 212,193 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Los Angeles Capital Management LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 57.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 155,487 shares of the company's stock after selling 212,193 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.06% of HCA Healthcare worth $46,669,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Todd Asset Management LLC boosted its holdings in shares of HCA Healthcare by 1.7% in the 4th quarter. Todd Asset Management LLC now owns 136,917 shares of the company's stock worth $41,096,000 after buying an additional 2,348 shares during the last quarter. Keeler Thomas Management LLC purchased a new position in shares of HCA Healthcare in the 4th quarter worth about $797,000. IFP Advisors Inc boosted its holdings in shares of HCA Healthcare by 23.2% in the 4th quarter. IFP Advisors Inc now owns 9,444 shares of the company's stock worth $2,835,000 after buying an additional 1,777 shares during the last quarter. Y Intercept Hong Kong Ltd boosted its holdings in shares of HCA Healthcare by 209.0% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 18,587 shares of the company's stock worth $5,579,000 after buying an additional 12,571 shares during the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in shares of HCA Healthcare in the 4th quarter worth about $1,060,000. Institutional investors own 62.73% of the company's stock.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on HCA. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Wells Fargo & Company downgraded shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Raymond James downgraded shares of HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Price Performance

Shares of HCA stock traded down $15.16 during trading on Friday, hitting $305.79. The company had a trading volume of 3,469,113 shares, compared to its average volume of 1,740,103. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock's 50-day moving average is $315.11 and its two-hundred day moving average is $349.91. The stock has a market capitalization of $75.94 billion, a price-to-earnings ratio of 13.92, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company earned $5.90 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.